Trinity Biotech Announces Breakthrough Results From Pre-Pivotal Trial of Disruptive Continuous Glucose Monitoring (CGM) Technology
Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced compelling results from its latest pre-pivotal clinical trial for its next-generation continuous glucose monitoring (CGM) system.
Trinity Biotech announces breakthrough in CGM technology
DUBLIN - Trinity Biotech plc (NASDAQ:TRIB), an Ireland-based biotech firm with a market capitalization of $13.24 million, revealed promising results from a recent pre-pivotal clinical trial for its innovative continuous glucose monitoring (CGM) system.
Trinity Biotech climbs after data for glucose monitoring device
Shares of Trinity Biotech (NASDAQ:TRIB) traded sharply higher on Tuesday after the Irish MedTech reported encouraging data from a pre-pivotal clinical trial for its next-gen continuous glucose monitoring (CGM) system.
Trinity Biotech announces results from pre-pivotal trial for CGM system
Trinity Biotech (TRIB) announced results from its latest pre-pivotal clinical trial for its next-generation continuous glucose monitoring
Trinity Biotech Shares Rise After Update on Next-Gen Blood-Sugar Monitoring Device
Shares of Trinity Biotech climbed after the company released what it called compelling results from a study of its next-generation continuous glucose monitoring system, a device used for diabetes management that measures blood sugar levels in real time.
What's Going On With Trinity Biotech Shares Tuesday?
Trinity stock is trading higher on Tuesday after the company announced results from its pre-pivotal clinical trial for its ...
Nasdaq1mon
Trinity Biotech plc Secures Additional Liquidity Through Amended Agreements with Perceptive Advisors to Support Comprehensive Transformation Plan
How does the funding impact Trinity Biotech's CGM technology development? The new liquidity supports the ongoing development of Trinity Biotech’s innovative continuous glucose monitoring ...
Morningstar1mon
Trinity Biotech Announces Amended Credit Agreement with Perceptive to Enhance Liquidity and Drive Transformation Plan
“The additional liquidity will support critical initiatives, including the development of our CGM technology, and further positions Trinity Biotech for growth and profitability. Combined with ...
Yahoo Finance19d
Trinity Biotech plc (TRIB)
The study assessed the analytical performance of CGM technology enhancements implemented by Trinity Biotech since acquiring t -Metabolomics Diagnostics, a deep-tech machine learning diagnostic ...
Finanznachrichten1mon
Trinity Biotech plc: Trinity Biotech Announces Amended Credit Agreement with Perceptive to Enhance Liquidity and Drive Transformation Plan
"The additional liquidity will support critical initiatives, including the development of our CGM technology, and further positions Trinity Biotech for growth and profitability. Combined with ...